Experimental prostate cancer drug trial halted early
Disease control
Terminated
This study tested a new drug called LAE001 in 33 men with metastatic prostate cancer that had stopped responding to hormone therapy. The goal was to check safety and find the right dose, and later see if it could lower PSA levels. The trial was terminated early, so results are li…
Phase: PHASE1, PHASE2 • Sponsor: Laekna Limited • Aim: Disease control
Last updated May 17, 2026 01:01 UTC